Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Paul Hudson
Pharma
Sanofi sticks to its guns on Beyfortus' blockbuster potential
“We’re confident that Beyfortus will be a blockbuster in 2024,” Thomas Triomphe, Sanofi’s EVP of vaccines, said on a call with analysts Thursday.
Fraiser Kansteiner
Jul 25, 2024 10:13am
Sanofi is going all in on Dupixent's next potential nod in COPD
Apr 25, 2024 12:37pm
Another slight drop in pay for Sanofi CEO Paul Hudson to €10.57M
Feb 26, 2024 11:34am
PhRMA taps Gilead CEO Dan O'Day as its new board chair
Feb 21, 2024 2:51pm
Amid supply constraints, Sanofi has big ambitions for Beyfortus
Feb 1, 2024 9:59am
Sanofi strategy pivot drags down stock after earnings report
Oct 27, 2023 10:57am
